Physician profile
Ann E Mcneill
NPI 1043843410
$6,796.02
in general payments reported to CMS, 2019-2025
25 companies · $1,024 in 2025
The $1,024 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,342 · 2022: $1,923 · 2023: $836 · 2024: $1,671 · 2025: $1,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,433 · Education: $97.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,433.48 |
| Education | $97.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,634.51 | 2021-2025 | |
| Janssen Biotech, INC. | $904.86 | 2021-2025 | Tremfya, Simponi Aria, Remicade |
| Ucb, INC. | $820.99 | 2021-2025 | Bimzelx, Cimzia |
| Amgen INC. | $817.09 | 2021-2025 | Enbrel, Otezla, Otezla |
| Pfizer INC. | $666.97 | 2021-2025 | |
| Lilly USA, LLC | $415.17 | 2021-2024 | Taltz |
| Astrazeneca Pharmaceuticals LP | $306.59 | 2021-2025 | Saphnelo |
| Mallinckrodt Hospital Products INC. | $252.66 | 2021-2025 | Acthar |
| Octapharma USA, INC. | $190.33 | 2021-2024 | Octagam Immune Globulin (Human) |
| Aurinia Pharma U.S., INC. | $98.76 | 2021-2023 | Lupkynis |
| Glaxosmithkline, LLC. | $98.75 | 2021-2025 | Benlysta |
| Novartis Pharmaceuticals Corporation | $98.15 | 2024 | |
| Janssen Scientific Affairs, LLC | $84.81 | 2025 | Tremfya |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.08 | 2023-2025 | Ofev, Cyltezo |
| Alexion Pharmaceuticals, INC. | $72.74 | 2021-2025 | Strensiq |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $70.55 | 2023-2025 | Purified Cortrophin Gel |
| E.R. Squibb & Sons, L.L.C. | $30.47 | 2021 | |
| Sobi, INC | $26.08 | 2025 | |
| Radius Health, INC. | $25.47 | 2023 | Tymlos |
| Sandoz INC. | $19.24 | 2025 | Jubbonti |
| Angiodynamics, INC. | $18.20 | 2025 | Auryon Laser System 100-120 Vac |
| Celltrion USA INC. | $17.93 | 2023 | Yuflyma |
| Kci USA, INC. | $17.11 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Ultragenyx Pharmaceutical INC. | $16.68 | 2021 | |
| Medtronic, INC. | $12.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Mcneill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.